PCMC
VTVT icon

Planning Capital Management Corporation’s vTv Therapeutics VTVT Stock Holding History

Planning Capital Management Corporation’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$8.48K Hold
625
– – 0.01% 458
2024
Q2 		$11K Hold
625
– – 0.01% 400
2024
Q1 		$14.7K Buy
+625
New +$7.95K 0.01% 357

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Planning Capital Management Corporation's VTVT Position: Q3 2024 in Review

Planning Capital Management Corporation held its vTv Therapeutics (VTVT) position steady in Q3 2024 at 625 shares worth $8.48K. The position accounts for 0.01% of the portfolio, ranked #458.

Planning Capital Management Corporation first reported a position in VTVT in Q1 2024 and has held it in 3 quarters since. The position peaked at $14.7K in Q1 2024. 20 funds tracked by Wall St. Rank hold VTVT as of Q3 2024.

  • Planning Capital Management Corporation held 625 shares of vTv Therapeutics worth $8.48K as of Q3 2024.
  • Planning Capital Management Corporation left its vTv Therapeutics share count unchanged in Q3 2024.
  • vTv Therapeutics made up 0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #458 holding.
  • Planning Capital Management Corporation first reported a position in vTv Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • Planning Capital Management Corporation's vTv Therapeutics position peaked at $14.7K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.